• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃泌素瘤40年评估:回归未来

Forty-year appraisal of gastrinoma. Back to the future.

作者信息

Ellison E C

机构信息

Department of Surgery, Ohio State University College of Medicine, Columbus, USA.

出版信息

Ann Surg. 1995 Oct;222(4):511-21; discussion 521-4. doi: 10.1097/00000658-199522240-00009.

DOI:10.1097/00000658-199522240-00009
PMID:7574931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1234884/
Abstract

OBJECTIVE

The author analyzed potential survival determinants in gastrinoma to characterize a possible uniform staging system and to determine whether complete surgical resection improves expected survival.

SUMMARY AND BACKGROUND DATA

Gastrinoma is an indolent yet malignant neuroendocrine tumor. The associated gastric acid hypersecretion can be controlled medically. Staging of gastrinoma is inconsistent and the role of surgical resection controversial.

METHODS

Seventy-four patients with gastrinoma with a minimum 5-year follow-up were assessed. Cox's proportional hazards regression model was used to examine the association of risk factors with survival.

RESULTS

The following factors had no effect on survival: age at diagnosis, sex, presence of lymph node metastases, associated multiple endocrine neoplasia, and method of ulcer treatment. The three unique determinants of survival were primary tumor size (relative risk, 1.534; p = 0.0005), liver metastases (relative risk, 2.947; p = 0.0209), and complete surgical resection (relative risk, 0.163; p = 0.0076). On the basis of these risk factors, a uniform staging system is proposed and predictive survival curves developed.

CONCLUSIONS

The primary determinants of survival in gastrinoma are the size of the primary tumor and liver metastases. Complete surgical resection reduces mortality, regardless of other factors.

摘要

目的

作者分析了胃泌素瘤潜在的生存决定因素,以确定一个可能统一的分期系统,并确定完整的手术切除是否能提高预期生存率。

总结与背景资料

胃泌素瘤是一种生长缓慢但具有恶性的神经内分泌肿瘤。其相关的胃酸分泌过多可通过药物控制。胃泌素瘤的分期并不一致,手术切除的作用也存在争议。

方法

对74例胃泌素瘤患者进行了评估,这些患者的随访时间至少为5年。采用Cox比例风险回归模型来检验危险因素与生存之间的关联。

结果

以下因素对生存无影响:诊断时的年龄、性别、淋巴结转移情况、是否伴有多发性内分泌腺瘤病以及溃疡治疗方法。生存的三个独立决定因素是原发肿瘤大小(相对风险,1.534;p = 0.0005)、肝转移(相对风险,2.947;p = 0.0209)以及完整的手术切除(相对风险,0.163;p = 0.0076)。基于这些危险因素,提出了一个统一的分期系统并绘制了预测生存曲线。

结论

胃泌素瘤生存的主要决定因素是原发肿瘤大小和肝转移情况。无论其他因素如何,完整的手术切除均可降低死亡率。

相似文献

1
Forty-year appraisal of gastrinoma. Back to the future.胃泌素瘤40年评估:回归未来
Ann Surg. 1995 Oct;222(4):511-21; discussion 521-4. doi: 10.1097/00000658-199522240-00009.
2
Changing therapy for gastrinoma.胃泌素瘤的治疗变更
HPB Surg. 1998;10(6):411-3. doi: 10.1155/1998/62935.
3
Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.晚期神经内分泌肿瘤患者进行积极手术切除的发病率和死亡率。
Arch Surg. 2003 Aug;138(8):859-66. doi: 10.1001/archsurg.138.8.859.
4
Surgical treatment and prognosis of gastrinoma.胃泌素瘤的外科治疗与预后
Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):799-805. doi: 10.1016/j.bpg.2005.05.003.
5
Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma.淋巴结清扫术对散发胃泌素瘤手术后生存的影响。
Br J Surg. 2012 Sep;99(9):1234-40. doi: 10.1002/bjs.8843.
6
50-year appraisal of gastrinoma: recommendations for staging and treatment.胃泌素瘤50年评估:分期与治疗建议
J Am Coll Surg. 2006 Jun;202(6):897-905. doi: 10.1016/j.jamcollsurg.2006.02.013. Epub 2006 May 2.
7
Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.1型多发性内分泌腺瘤病中胃泌素瘤和胰岛素瘤的手术治疗
J Natl Compr Canc Netw. 2006 Feb;4(2):148-53. doi: 10.6004/jnccn.2006.0015.
8
Recurrence after surgical resection of gastrinoma: who, when, where and why?胃泌素瘤切除术后复发:何人、何时、何地及为何?
Eur J Gastroenterol Hepatol. 2012 Apr;24(4):368-74. doi: 10.1097/MEG.0b013e328350f816.
9
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).MEN1 患者胃泌素瘤的预后因素和生存情况:荷兰 MEN 研究组(DMSG)的结果。
J Surg Oncol. 2019 Nov;120(6):966-975. doi: 10.1002/jso.25667. Epub 2019 Aug 10.
10
[Surgical therapy of gastrinoma with associated Zollinger-Ellison syndrome].[胃泌素瘤伴佐林格-埃利森综合征的外科治疗]
Z Gastroenterol. 1996 Aug;34(8):465-72.

引用本文的文献

1
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.1型多发性内分泌腺瘤病的死亡原因及预后因素:一项前瞻性研究:106例MEN1/卓艾综合征患者与1613例有或无胰腺内分泌肿瘤的文献报道的MEN1患者的比较
Medicine (Baltimore). 2013 May;92(3):135-181. doi: 10.1097/MD.0b013e3182954af1.
2
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.遗传性胰腺内分泌肿瘤综合征:分子发病机制、诊断、管理及争议方面的进展
Cancer. 2008 Oct 1;113(7 Suppl):1807-43. doi: 10.1002/cncr.23648.
3
Zollinger-Ellison Syndrome.佐林格-埃利森综合征
Curr Treat Options Gastroenterol. 2003 Apr;6(2):163-170. doi: 10.1007/s11938-003-0017-6.
4
Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).生长抑素受体闪烁扫描术在卓-艾综合征患者管理中的应用。卓-艾综合征研究与学习小组(GRESZE)。
Gut. 1997 Jul;41(1):107-14. doi: 10.1136/gut.41.1.107.

本文引用的文献

1
Intestinal mucosa in the Zollinger-Ellison syndrome.佐林格-埃利森综合征中的肠黏膜。
Gut. 1965 Jun;6(3):286-9. doi: 10.1136/gut.6.3.286.
2
Zollinger-Ellison syndrome with diarrhoea and malabsorption. Observations on a patient before and after pancreatic islet-cell tumour removal with-out resort.伴有腹泻和吸收不良的佐林格-埃利森综合征。对一例胰岛细胞瘤切除术前及术后未使用[具体药物,原文未提及]的患者的观察。
Lancet. 1960 Jul 16;2(7142):131-4. doi: 10.1016/s0140-6736(60)91271-x.
3
Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas.空肠原发性消化性溃疡与胰腺胰岛细胞瘤相关。
Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8.
4
Flow cytometry and Zollinger-Ellison syndrome: relationship to clinical course.流式细胞术与卓-艾综合征:与临床病程的关系
Gastroenterology. 1993 Sep;105(3):799-813. doi: 10.1016/0016-5085(93)90898-m.
5
Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome. Influence of gastrinoma growth and long-term omeprazole treatment.卓-艾综合征患者胃内分泌细胞的演变。胃泌素瘤生长及长期奥美拉唑治疗的影响。
Dig Dis Sci. 1993 Jul;38(7):1307-17. doi: 10.1007/BF01296083.
6
Biologic behavior of sporadic gastrinoma located to the right and left of the superior mesenteric artery.位于肠系膜上动脉左右两侧的散发性胃泌素瘤的生物学行为
Am J Surg. 1993 Jan;165(1):101-5; discussion 105-6. doi: 10.1016/s0002-9610(05)80411-8.
7
Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma.佐林格-埃利森综合征的手术改变了胃泌素瘤的自然病程。
Ann Surg. 1994 Sep;220(3):320-8; discussion 328-30. doi: 10.1097/00000658-199409000-00008.
8
The role of surgery in children with the Zollinger-Ellison syndrome.手术在佐林格-埃利森综合征患儿中的作用。
Surgery. 1982 Oct;92(4):682-92.
9
Resection of gastrinoma in the Zollinger-Ellison syndrome.卓-艾综合征中胃泌素瘤的切除术
Gastroenterology. 1982 May;82(5 Pt 1):953-6.
10
Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome.92例连续性卓-艾综合征患者的外科治疗结果。
Ann Surg. 1981 Dec;194(6):692-7. doi: 10.1097/00000658-198112000-00005.